DTIL

SEC source: 0001209191-22-035405 · doc4.xml · nonDerivative · entry 1

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,279

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2022.

F2 · price: Each RSU represents a contingent right to receive one share of the Company's Common Stock.

SEC source: 0001209191-22-035391 · doc4.xml · derivative · entry 2

Barton Shane · CIK 0001836297 · VP & Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,120

Underlying: Common Stock · 6,061 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's Common Stock.

F3 · derivative.exercise_date: On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

F3 · derivative.expiration_date: On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC source: 0001209191-22-035391 · doc4.xml · nonDerivative · entry 1

Barton Shane · CIK 0001836297 · VP & Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,720

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2022.

F2 · price: Each RSU represents a contingent right to receive one share of the Company's Common Stock.

SEC source: 0001209191-22-032729 · doc4.xml · derivative · entry 1

Brown Melinda · CIK 0001682988 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 376,683

Underlying: Common Stock · 376,683 shares

Expires 2032-05-25

F1 · derivative.exercise_date: The option vests in 36 substantially equal monthly installments following May 26, 2022, such that the option shall be fully vested on May 26, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0001209191-22-028447 · doc4.xml · derivative · entry 1

Frankel Stanley · CIK 0001855726 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,951

Underlying: Common Stock · 156,951 shares

Expires 2032-05-09

F1 · derivative.exercise_date: The option vests on the earlier to occur of (i) May 10, 2023 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0001209191-22-028449 · doc4.xml · derivative · entry 1

Germano Geno J · CIK 0001424383 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,951

Underlying: Common Stock · 156,951 shares

Expires 2032-05-09

F1 · derivative.exercise_date: The option vests on the earlier to occur of (i) May 10, 2023 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0001209191-22-028445 · doc4.xml · derivative · entry 1

Schinazi Raymond F · CIK 0001397607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,951

Underlying: Common Stock · 156,951 shares

Expires 2032-05-09

F1 · derivative.exercise_date: The option vests on the earlier to occur of (i) May 10, 2023 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0001209191-22-028453 · doc4.xml · derivative · entry 1

Pire Shari Lisa · CIK 0001892150 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,951

Underlying: Common Stock · 156,951 shares

Expires 2032-05-09

F1 · derivative.exercise_date: The option vests on the earlier to occur of (i) May 10, 2023 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0001209191-22-028451 · doc4.xml · derivative · entry 1

Wadsworth Samuel C. · CIK 0001653056 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,951

Underlying: Common Stock · 156,951 shares

Expires 2032-05-09

F1 · derivative.exercise_date: The option vests on the earlier to occur of (i) May 10, 2023 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0001209191-22-028443 · doc4.xml · derivative · entry 1

Buehler Kevin · CIK 0001792722 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,951

Underlying: Common Stock · 156,951 shares

Expires 2032-05-09

F1 · derivative.exercise_date: The option vests on the earlier to occur of (i) May 10, 2023 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0001209191-22-026041 · doc4.xml · nonDerivative · entry 2

List Alan · CIK 0001858530 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,260

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.

SEC source: 0001209191-22-026041 · doc4.xml · derivative · entry 3

List Alan · CIK 0001858530 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,055

Underlying: Common Stock · 26,035 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's Common Stock.

F4 · derivative.exercise_date: On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on April 26, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

F4 · derivative.expiration_date: On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on April 26, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC source: 0001209191-22-026041 · doc4.xml · nonDerivative · entry 1

List Alan · CIK 0001858530 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on April 26, 2022.

F2 · price: Each RSU represents a contingent right to receive one share of the Company's Common Stock.

SEC source: 0001209191-22-024302 · doc4.xml · derivative · entry 2

Buehler Kevin · CIK 0001792722 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,701

Underlying: Common Stock · 5,701 shares

Expires not disclosed

F2 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.

F3 · derivative.exercise_date: The RSUs shall be fully vested on the first anniversary of the grant date of such RSUs, subject to the Reporting Person continuing in service through each such vesting date.

F3 · derivative.expiration_date: The RSUs shall be fully vested on the first anniversary of the grant date of such RSUs, subject to the Reporting Person continuing in service through each such vesting date.

SEC source: 0001209191-22-024302 · doc4.xml · derivative · entry 1

Buehler Kevin · CIK 0001792722 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,763

Underlying: Common Stock · 8,763 shares

Expires 2032-04-10

F1 · derivative.exercise_date: The option vests in 12 substantially equal monthly installments following April 11, 2022, such that the option shall be fully vested on April 11, 2023, subject to the Reporting Person continuing in service through each such vesting date.

SEC source: 0001209191-22-020793 · doc4.xml · derivative · entry 2

Amoroso Michael · CIK 0001830874 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,544

Underlying: Common Stock · 307,544 shares

Expires not disclosed

F2 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.

F3 · derivative.exercise_date: The RSUs shall vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

F3 · derivative.expiration_date: The RSUs shall vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC source: 0001209191-22-020793 · doc4.xml · derivative · entry 1

Amoroso Michael · CIK 0001830874 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 482,771

Underlying: Common Stock · 482,771 shares

Expires 2032-03-20

F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on March 21, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC source: 0001209191-22-020337 · doc4.xml · nonDerivative · entry 1

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,189

F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.05 to $3.09. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

SEC source: 0001209191-22-016629 · doc4.xml · derivative · entry 7

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,659

Underlying: Common Stock · 82,659 shares

Expires not disclosed

F2 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.

F3 · derivative.exercise_date: The RSUs shall vest in three equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

F3 · derivative.expiration_date: The RSUs shall vest in three equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC source: 0001209191-22-016629 · doc4.xml · derivative · entry 6

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,271

Underlying: Common Stock · 131,271 shares

Expires 2032-03-02

F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on March 3, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC source: 0001209191-22-016664 · doc4.xml · derivative · entry 2

List Alan · CIK 0001858530 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,343

Underlying: Common Stock · 88,343 shares

Expires not disclosed

F2 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.

F3 · derivative.exercise_date: The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

F3 · derivative.expiration_date: The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC source: 0001209191-22-016664 · doc4.xml · derivative · entry 1

List Alan · CIK 0001858530 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,299

Underlying: Common Stock · 140,299 shares

Expires 2032-03-02

F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on March 3, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC source: 0001209191-22-016650 · doc4.xml · derivative · entry 2

JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,401

Underlying: Common Stock · 98,401 shares

Expires not disclosed

F2 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.

F3 · derivative.exercise_date: The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

F3 · derivative.expiration_date: The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC source: 0001209191-22-016650 · doc4.xml · derivative · entry 1

JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,271

Underlying: Common Stock · 156,271 shares

Expires 2032-03-02

F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on March 3, 2023 and vests in substantially equal installments at the end of each successive three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC source: 0001209191-22-016641 · doc4.xml · derivative · entry 5

Barton Shane · CIK 0001836297 · VP & Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,161

Underlying: Common Stock · 38,161 shares

Expires not disclosed

F2 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.

F3 · derivative.exercise_date: The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

F3 · derivative.expiration_date: The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC source: 0001209191-22-016641 · doc4.xml · derivative · entry 4

Barton Shane · CIK 0001836297 · VP & Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,604

Underlying: Common Stock · 60,604 shares

Expires 2032-03-02

F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on March 3, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC source: 0001209191-22-016614 · doc4.xml · derivative · entry 4

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,185

Underlying: Common Stock · 153,185 shares

Expires not disclosed

F2 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.

F3 · derivative.exercise_date: The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

F3 · derivative.expiration_date: The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC source: 0001209191-22-016614 · doc4.xml · derivative · entry 3

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 243,274

Underlying: Common Stock · 243,274 shares

Expires 2032-03-02

F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on March 3, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC source: 0001209191-22-016629 · doc4.xml · nonDerivative · entry 5

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,573

SEC source: 0001209191-22-016641 · doc4.xml · nonDerivative · entry 3

Barton Shane · CIK 0001836297 · VP & Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,659

SEC source: 0001209191-22-016614 · doc4.xml · nonDerivative · entry 2

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,512

SEC source: 0001209191-21-013922 · doc4.xml · derivative · entry 3

JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,626

Underlying: Common Stock · 21,514 shares

Expires 2021-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001209191-21-063848 · doc4.xml · derivative · entry 1

Wadsworth Samuel C. · CIK 0001653056 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,360

Underlying: Common Stock · 55,360 shares

Expires 2031-11-07

F1 · derivative.exercise_date: The option vests in 36 substantially equal monthly installments following November 8, 2021, such that the option shall be fully vested on November 8, 2024.

SEC source: 0001209191-21-063837 · doc4.xml · derivative · entry 1

Pire Shari Lisa · CIK 0001892150 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,360

Underlying: Common Stock · 55,360 shares

Expires 2031-11-07

F1 · derivative.exercise_date: The option vests in 36 substantially equal monthly installments following November 8, 2021, such that the option shall be fully vested on November 8, 2024.

SEC source: 0001209191-21-060890 · doc4.xml · derivative · entry 2

Amoroso Michael · CIK 0001830874 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,208

Underlying: Common Stock · 24,208 shares

Expires not disclosed

F2 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.

F3 · derivative.exercise_date: The RSUs shall vest on October 15, 2022, subject to the Reporting Person's continued service to the Company through the vesting date.

F3 · derivative.expiration_date: The RSUs shall vest on October 15, 2022, subject to the Reporting Person's continued service to the Company through the vesting date.

SEC source: 0001209191-21-060890 · doc4.xml · derivative · entry 1

Amoroso Michael · CIK 0001830874 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 850,000

Underlying: Common Stock · 850,000 shares

Expires 2031-10-14

F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on October 15, 2022 and thereafter in twelve equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC source: 0001209191-22-016629 · doc4.xml · nonDerivative · entry 4

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,524

SEC source: 0001209191-22-016641 · doc4.xml · nonDerivative · entry 2

Barton Shane · CIK 0001836297 · VP & Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,898

SEC source: 0001209191-22-016614 · doc4.xml · nonDerivative · entry 1

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,798

SEC source: 0001209191-21-043206 · doc4.xml · derivative · entry 3

THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,255

Underlying: Common Stock · 30,000 shares

Expires 2027-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001209191-21-043206 · doc4.xml · nonDerivative · entry 2

THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,513

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.61 to $10.69. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-043206 · doc4.xml · nonDerivative · entry 1

THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,513

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-042844 · doc4.xml · derivative · entry 3

THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,255

Underlying: Common Stock · 15,000 shares

Expires 2027-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001209191-21-042844 · doc4.xml · nonDerivative · entry 2

THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,513

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.75 to $10.81. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-042844 · doc4.xml · nonDerivative · entry 1

THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,513

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-041996 · doc4.xml · derivative · entry 6

THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,255

Underlying: Common Stock · 10,000 shares

Expires 2027-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001209191-21-041996 · doc4.xml · nonDerivative · entry 4

THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,513

SEC source: 0001209191-21-041996 · doc4.xml · nonDerivative · entry 3

THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,513

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-041996 · doc4.xml · derivative · entry 5

THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,255

Underlying: Common Stock · 10,000 shares

Expires 2027-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001209191-21-041996 · doc4.xml · nonDerivative · entry 2

THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,513

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.39 to $10.48. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.